Cargando…
The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway
SIMPLE SUMMARY: Targeted nanomedicine-based approaches that aim at the simultaneous delivery of synergistic drug combinations to multiple cellular populations are of high relevance for tackling heterogeneity on solid tumors. Considering that cancer stem cells (CSC) may originate from non-stem cancer...
Autores principales: | Cruz, Ana F., Caleiras, Mariana B., Fonseca, Nuno A., Gonçalves, Nélio, Mendes, Vera M., Sampaio, Susana F., Moura, Vera, Melo, Joana B., Almeida, Ramiro D., Manadas, Bruno, Simões, Sérgio, Moreira, João N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235382/ https://www.ncbi.nlm.nih.gov/pubmed/34207464 http://dx.doi.org/10.3390/cancers13123052 |
Ejemplares similares
-
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer
por: Valério-Fernandes, Ângela, et al.
Publicado: (2022) -
Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
por: Romano, Sofia, et al.
Publicado: (2018) -
Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
por: Carvalho, Laura Sofia, et al.
Publicado: (2021) -
Intracellular trafficking of ceramide by ceramide transfer protein
por: Hanada, Kentaro
Publicado: (2010) -
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
por: Brignole, Chiara, et al.
Publicado: (2021)